TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Medical - Devices

Healthcare
$2.45 +0.49%

+$0.02 today

Market cap
$151.16M
Beta
0.49
P/E (TTM)
-7.4
EPS (TTM)
-$0.53
52W Low $2.20High $7.95

Volume 0.40M

Average 0.38M

TLSI Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

TriSalus Life Sciences, Inc.NASDAQ: TLSI

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 51.54M shares rose 80.7% year over year, ahead of the +65.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 10.0% from the prior quarter. Over 3 fiscal years it compounded at +18.4% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +80.7% holds above the trailing-twelve-month pace of +65.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
51.54M+10.0% QoQ
Last fiscal yearDec 2025
49.19M+85.6% YoY
LTMMar 2026
43.59M+65.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+80.7%——
1 year+85.6%——
3-year CAGR+18.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
49.19M USD
Year-over-year change
+85.6%
4-year CAGR
+12.0%

Weighted Avg Shares vs competitors

How TLSI compares with its peers on the latest reported figures

  • TLSI's LTM Mar 2026 weighted avg shares of 43.59M shares is the 6th highest of the 11 companies compared; the peer median is 45.64M shares.
  • Its year-over-year change of +65.4% is the 3rd highest of 11, against a peer median of +7.1%.
  • Over three fiscal years its annual growth of +18.4% compares with a peer median of +8.9%.
TLSI Competitors Peer median
Weighted Avg Shares for TLSI and competitors
Company Period LTM YoY 3-year CAGR
OWLTOwlet, Inc.LTM Mar 2026149.39M +1085.6%+313.6%
MXCTMaxCyte, Inc.LTM Mar 2026106.51M +1.3%+1.5%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
TLSITriSalus Life Sciences, Inc.LTM Mar 202643.59M +65.4%+18.4%
ARMPArmata Pharmaceuticals, Inc.LTM Mar 202636.32M +0.4%+1.9%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
PREPrenetics Global LimitedLTM Mar 202615.04M +18.8%+40.5%
LNSRLENSAR, Inc.LTM Mar 202612.05M +3.8%+5.6%
Peer median (excluding TLSI) 45.64M+7.1%+8.9%

Competitors are the stored peer set for TLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.4M12.4M18.51M29.43M45.15M
Cost of Revenue1.19M2.26M2.61M4.1M6.97M
Gross Profit7.21M10.14M15.91M25.33M38.19M
Gross Margin85.8%81.8%85.9%86.1%84.6%
Research & Development14.22M21.36M29.84M17.69M14.97M
Selling, General & Admin17.02M25.22M40.55M43.81M50.17M
Operating Expenses31.24M46.58M70.38M61.49M65.13M
Depreciation & Amortization464K414K684K744K626K
EBITDA(26.62M)(46.76M)(58.65M)(32.39M)(33.05M)
EBITDA Margin-316.8%-377.2%-316.9%-110.0%-73.2%
Operating Income(24.03M)(36.44M)(54.48M)(36.17M)(26.95M)
Operating Margin-286.1%-293.9%-294.3%-122.9%-59.7%
Interest Income0180K431K404K555K
Interest Expense1.76M1K16K3.09M5.54M
Other Income / Expenses(4.81M)(10.74M)(4.88M)6.13M(12.27M)
Income Before Tax(28.84M)(47.18M)(59.35M)(30.04M)(39.22M)
Pre-Tax Margin-343.3%-380.5%-320.6%-102.1%-86.9%
Income Tax Expense3K9K9K6K7K
Net Income(28.85M)(47.19M)(59.36M)(33.23M)(39.23M)
Net Margin-343.4%-380.6%-320.7%-112.9%-86.9%
EPS (Basic)(0.92)(1.59)(2.23)(1.25)(1.84)
EPS (Diluted)(0.92)(1.59)(2.23)(1.25)(1.84)
Weighted Avg Shares31.25M29.61M26.47M26.5M49.19M
Weighted Avg Shares (Diluted)31.25M29.61M26.47M26.5M37.9M

TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Intrinsic Alpha fair value

Locked

Current Price

$2.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.